Cheplapharm Arzneimittel GmbH

Cheplapharm Arzneimittel GmbH is a Gesellschaft mit beschränkter Haftung in Greifswald, Germany that reports a consolidating parent, so its accounts form part of a larger group.

The LEI has been on record for 11 years, since 6 May 2015. That is about 5 years earlier than the median LEI in Germany, which dates from 2020 — an early adopter by local standards.

The next annual re-validation is due 9 May 2027, 190 days from now.

The record has not changed since we began archiving it on 6 Jul 2026. Any future change to name, status, address, ownership or renewal date will be captured here, because GLEIF publishes only the current state and superseded values are otherwise lost.

The entity is registered with Commercial Register under registry number HRB 5896, and the LEI itself is issued and maintained by Herausgebergemeinschaft Wertpapier-Mitteilungen Keppler, Lehmann GmbH & Co. KG, one of the Local Operating Units accredited by GLEIF.

Beyond the LEI, 2 ISINs are mapped to this entity in the GLEIF cross-reference files.

Its ultimate accounting-consolidating parent — the highest entity in the chain that consolidates it into published accounts — is Braun Invest Holding GmbH, which is also its direct parent, so the consolidation chain is one level deep.

The LEI registration is issued, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.